Study of Efficacy of Fevipiprant in Patients With Nasal Polyposis and Asthma
Clinical trial NCT03681093 · COMPLETED
Trial details
- NCT number
- NCT03681093
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-26
- Primary completion
- 2020-05-29
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.